A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS)
Conditions: Cognitive Impairment Associated With Schizophrenia; Schizophrenia Interventions: Drug: BIIB104; Other: Placebo Sponsor: Biogen Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials